Related Experiment Video
Updated: Jul 28, 2026
08:16
Mimicking and Manipulating Pancreatic Acinar-to-Ductal Metaplasia in 3-dimensional Cell Culture
Published on: February 11, 2019
A multi-stage model of adenoma development
1Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
Journal of Theoretical Biology
|October 18, 2000
Summary
Mathematical modeling of adenoma development aids colorectal cancer prevention. The multi-stage model explains adenoma prevalence, size, and clustering, incorporating population risk heterogeneity.
Area of Science:
- Oncology
- Mathematical Biology
- Gastroenterology
Background:
- Colorectal carcinomas often arise from adenomatous polyps (adenomas).
- Adenoma identification and removal are key to colorectal cancer prevention.
- Understanding adenoma development is crucial for optimizing screening and prevention strategies.
Purpose of the Study:
- To adapt the multi-stage model of carcinogenesis for adenoma development and growth.
- To assess the model's ability to fit various adenoma data characteristics.
- To explore the role of population heterogeneity in adenoma risk.
Main Methods:
- Adaptation of the multi-stage carcinogenesis model.
- Fitting the model to adenoma prevalence by age, size distribution, and clustering.
- Incorporation of population risk heterogeneity.
Main Results:
- The adapted model successfully fits adenoma prevalence, size distribution, and clustering data.
- Population heterogeneity in risk is necessary to explain adenoma clustering.
- The model accounts for adenoma development in familial adenomatous polyposis and hereditary non-polyposis colorectal cancer.
Conclusions:
- Mathematical modeling provides valuable insights into adenoma biology and colorectal cancer progression.
- The multi-stage model, incorporating heterogeneity, can inform prevention and screening strategies.
- The model's adaptability extends to specific hereditary colorectal cancer syndromes.
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:35Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:24Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...